Definiens AG

Unspecified (Unknown)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£240,333

Aug 17 - Feb 21

Immune-checkpoint therapy in non-small cell lung carcinoma:molecular characterisation of tumour microenvironment to improve anti-PD1/PD-L1 drug class.

MRC award to University of Liverpool and Alexander Haragan

£1,799,716

Nov 16 - Jun 25

MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics

MRC award to University of Liverpool and Munir Pirmohamed

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}